Persistent Antibody Clonotypes Dominate the Serum Response to Influenza over Multiple Years and Repeated Vaccinations.
暂无分享,去创建一个
George Georgiou | Jonathan R. McDaniel | Leontios Pappas | Antonio Lanzavecchia | Davide Corti | Jiwon Jung | D. Boutz | A. Lanzavecchia | G. Georgiou | G. Ippolito | D. Corti | Jiwon Lee | Philipp Paparoditis | Andrew P. Horton | Alexander Fruehwirth | Jiwon Jung | Dania A. Hussein | Yuri Tanno | L. Pappas | Gregory C Ippolito | Jonathan R McDaniel | Andrew P Horton | Alexander Frühwirth | Daniel R Boutz | Jiwon Lee | Philipp Paparoditis | Dania A Hussein | Yuri Tanno | Philipp C G Paparoditis
[1] J. Yewdell,et al. Is It Possible to Develop a "Universal" Influenza Virus Vaccine? Outflanking Antibody Immunodominance on the Road to Universal Influenza Vaccination. , 2018, Cold Spring Harbor perspectives in biology.
[2] T. Kepler,et al. Memory B Cells that Cross‐React with Group 1 and Group 2 Influenza A Viruses Are Abundant in Adult Human Repertoires , 2018, Immunity.
[3] I. Wilson,et al. A Perspective on the Structural and Functional Constraints for Immune Evasion: Insights from Influenza Virus. , 2017, Journal of molecular biology.
[4] A. Lanzavecchia,et al. Tackling influenza with broadly neutralizing antibodies , 2017, Current Opinion in Virology.
[5] Jonathan R. McDaniel,et al. Potent and broad HIV-neutralizing antibodies in memory B cells and plasma , 2017, Science Immunology.
[6] Nicole M. Bouvier,et al. Defining the antibody cross-reactome against the influenza virus surface glycoproteins , 2017, Nature Immunology.
[7] Matthew Angel,et al. Defining B Cell Immunodominance to Viruses , 2017, Nature Immunology.
[8] Baoshan Zhang,et al. Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccination , 2016, Nature Medicine.
[9] S. Hensley,et al. Antibodies with ‘Original Antigenic Sin’ Properties Are Valuable Components of Secondary Immune Responses to Influenza Viruses , 2016, PLoS pathogens.
[10] Cinque S. Soto,et al. Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses , 2016, Cell.
[11] P. Collins,et al. Structure and Function Analysis of an Antibody Recognizing All Influenza A Subtypes , 2016, Cell.
[12] K. Roskin,et al. Defining antigen-specific plasmablast and memory B cell subsets in blood following viral infection and vaccination of humans , 2016, Nature Immunology.
[13] James O. Lloyd-Smith,et al. Potent protection against H5N1 and H7N9 influenza via childhood hemagglutinin imprinting , 2016, Science.
[14] George Georgiou,et al. Ultra-high-throughput sequencing of the immune receptor repertoire from millions of lymphocytes , 2016, Nature Protocols.
[15] Jin Hyang Kim,et al. Prior infection with influenza virus but not vaccination leaves a long-term immunological imprint that intensifies the protective efficacy of antigenically drifted vaccine strains. , 2016, Vaccine.
[16] T. Kepler,et al. Immunogenic Stimulus for Germline Precursors of Antibodies that Engage the Influenza Hemagglutinin Receptor-Binding Site. , 2015, Cell reports.
[17] Adrian Apetri,et al. A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen , 2015, Science.
[18] J. Mascola,et al. Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection , 2015, Nature Medicine.
[19] T. Kepler,et al. Viral Receptor-Binding Site Antibodies with Diverse Germline Origins , 2015, Cell.
[20] D. Cummings,et al. Estimating the Life Course of Influenza A(H3N2) Antibody Responses from Cross-Sectional Data , 2015, PLoS biology.
[21] P. Palese,et al. Advances in the development of influenza virus vaccines , 2015, Nature Reviews Drug Discovery.
[22] George Georgiou,et al. Next-generation sequencing and protein mass spectrometry for the comprehensive analysis of human cellular and serum antibody repertoires. , 2015, Current opinion in chemical biology.
[23] Min Huang,et al. High Preexisting Serological Antibody Levels Correlate with Diversification of the Influenza Vaccine Response , 2015, Journal of Virology.
[24] George Georgiou,et al. In-depth determination and analysis of the human paired heavy- and light-chain antibody repertoire , 2014, Nature Medicine.
[25] Judith M. Fonville,et al. Antibody landscapes after influenza virus infection or vaccination , 2014, Science.
[26] Mark M. Davis,et al. Distinct Patterns of B-Cell Activation and Priming by Natural Influenza Virus Infection Versus Inactivated Influenza Vaccination , 2014, The Journal of infectious diseases.
[27] Qing Zhu,et al. Rapid development of broadly influenza neutralizing antibodies through redundant mutations , 2014, Nature.
[28] Y. Iba,et al. Receptor mimicry by antibody F045–092 facilitates universal binding to the H3 subtype of influenza virus , 2014, Nature Communications.
[29] Edward M. Marcotte,et al. Proteomic Identification of Monoclonal Antibodies from Serum , 2014, Analytical chemistry.
[30] Andrew D. Ellington,et al. Identification and characterization of the constituent human serum antibodies elicited by vaccination , 2014, Proceedings of the National Academy of Sciences.
[31] Damian C. Ekiert,et al. Structure of a Classical Broadly Neutralizing Stem Antibody in Complex with a Pandemic H2 Influenza Virus Hemagglutinin , 2013, Journal of Virology.
[32] Antonio Lanzavecchia,et al. Broadly neutralizing antiviral antibodies. , 2013, Annual review of immunology.
[33] Jason J. Lavinder,et al. Molecular deconvolution of the monoclonal antibodies that comprise the polyclonal serum response , 2013, Proceedings of the National Academy of Sciences.
[34] John Steel,et al. Cross-neutralization of influenza A viruses mediated by a single antibody loop , 2012, Nature.
[35] Mark Mulligan,et al. Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells , 2012, Proceedings of the National Academy of Sciences.
[36] Andrew D. Ellington,et al. Antibody Repertoires in Humanized NOD-scid-IL2Rγnull Mice and Human B Cells Reveals Human-Like Diversification and Tolerance Checkpoints in the Mouse , 2012, PloS one.
[37] T. Kepler,et al. H3N2 Influenza Infection Elicits More Cross-Reactive and Less Clonally Expanded Anti-Hemagglutinin Antibodies Than Influenza Vaccination , 2011, PloS one.
[38] J. Skehel,et al. A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins , 2011, Science.
[39] Surender Khurana,et al. Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin , 2011, Proceedings of the National Academy of Sciences.
[40] J. Yewdell,et al. Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection , 2011, The Journal of experimental medicine.
[41] G. Rimmelzwaan,et al. Prevalence of Antibodies against Seasonal Influenza A and B Viruses in Children in Netherlands , 2011, Clinical and Vaccine Immunology.
[42] Anthony S. Fauci,et al. Influenza vaccines for the future. , 2010, The New England journal of medicine.
[43] G. Nabel,et al. Induction of Broadly Neutralizing H1N1 Influenza Antibodies by Vaccination , 2010, Science.
[44] K. Subbarao,et al. Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine. , 2010, The Journal of clinical investigation.
[45] A. Falsey,et al. Peak frequencies of circulating human influenza-specific antibody secreting cells correlate with serum antibody response after immunization. , 2010, Vaccine.
[46] Ron A M Fouchier,et al. Antigenic and Genetic Characteristics of Swine-Origin 2009 A(H1N1) Influenza Viruses Circulating in Humans , 2009, Science.
[47] D. Jarrossay,et al. Clonal dissection of the human memory B‐cell repertoire following infection and vaccination , 2009, European journal of immunology.
[48] Boguslaw Stec,et al. Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses , 2009, Nature Structural &Molecular Biology.
[49] Patrick C. Wilson,et al. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus , 2008, Nature.
[50] Andreas Zell,et al. EDISA: extracting biclusters from multiple time-series of gene expression profiles , 2007, BMC Bioinformatics.
[51] R. Weiss,et al. A sensitive retroviral pseudotype assay for influenza H5N1‐neutralizing antibodies , 2007, Influenza and other respiratory viruses.
[52] Paul G Thomas,et al. Influenza and the challenge for immunology , 2006, Nature Immunology.
[53] Antonio Lanzavecchia,et al. Maintenance of Serological Memory by Polyclonal Activation of Human Memory B Cells , 2002, Science.
[54] A. Douglas,et al. The evolution of human influenza viruses. , 2001, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[55] R. Ahmed,et al. Humoral immunity due to long-lived plasma cells. , 1998, Immunity.
[56] J. T. Curtis,et al. An Ordination of the Upland Forest Communities of Southern Wisconsin , 1957 .
[57] J. Aizpurua,et al. Potent protection against H5N1 and H7N9 influenza via childhood hemagglutinin imprinting , 2016 .
[58] J. Skehel,et al. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. , 2000, Annual review of biochemistry.